Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01618539 · ClinicalTrials.gov registry record
Correlation of Bispectral Index Score and Total Intravenous Anesthesia (TIVA)
A clinical trial, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- 31
- Enrollment target
NCT01618539: Clinical Trial study, sponsored by Rutgers, The State University of New Jersey.
NCT01618539 is a clinical trial that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01618539 was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- 31 participants
- Enrollment target
Study Summary
General Anesthesia is usually produced by an intravenous agent and then maintained with a breathing agent till the surgery is completed. However, there is a recent trend to produce and maintain general anesthesia solely with an intravenous agent, such as propofol, in view of its advantages. This delivery method is called Total Intravenous Anesthesia (TIVA). The depth of general anesthesia can be measured by an anesthetic depth monitoring device called Bispectral Index (BIS). The use of BIS to determine the depth of anesthesia has been well established whenever a breathing agent is used to maintain general anesthesia. However, the validity of using BIS with TIVA has not been adequately investigated. This study will compare the BIS values at different doses of TIVA in order to establish any correlation between the two. If such a correlation is established, BIS monitoring can safely be recommended to determine anesthetic depth under TIVA.
Primary Outcome
Correlation between various infusion rates of propofol administered during TIVA and BIS values during the first 3 hours of the operative procedure
Interventions
- DRUG propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-09 |
Why NCT01618539 stopped before completion
NCT01618539 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which propofol is the first listed.
NCT01618539 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01618539 about?
NCT01618539 is a clinical study titled "Correlation of Bispectral Index Score and Total Intravenous Anesthesia (TIVA)". General Anesthesia is usually produced by an intravenous agent and then maintained with a breathing agent till the surgery is completed. However, there is a recent trend to produce and maintain general anesthesia solely with an intravenous agent, such as propofol, in view of its advantages. This del...
What is the current status of trial NCT01618539?
This trial is currently terminated. The enrollment target is 31 participants. The study started on 2012-06. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01618539?
The interventions under investigation include: propofol (DRUG).
Who is sponsoring clinical trial NCT01618539?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia